Altered Bowel Habits Presented by: Wa’ad Alotibi 311200661.

Slides:



Advertisements
Similar presentations
Managing Crohn’s Disease through Nutritional Intervention
Advertisements

Inflammatory Bowel Disease
Gastrointestinal Block Pathology lecture Dec, 2013 Dr. Maha Arafah Dr. Ahmed Al Humaidi Inflammatory bowel disease.
 A 77-year-old comes to the ED with complaints of diarrhea, rectal pain and urgency for 3 days. His History is notable for Ischemic Heart disease, Hyperlipidemia,
Ulcerative Colitis.
Inflammatory Intestinal Diseases. Ulcerative Colitis Unknown etiology Mucosal inflammation and ulceration in the large intestine Always involves the rectum.
Lower GI Tract - Part One NFSC Clinical Nutrition McCafferty.
Inflammatory Bowel Disease Ulcerative colitis (UC) Kristina Blaslov Mentor: A. Žmegač Horvat.
Ulcerative Colitis By Aicha N. Saba MD4. What is it? Ulcerative colitis is an inflammatory bowel disease that causes long-lasting inflammation and ulcers.
On physical examination, the abdomen is tender over the colon.
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Pathology of the Large Intestine Dr. Shaun Walsh Ninewells Hospital Dundee.
Crohn’s disease - A Review of Symptoms and Treatment
Ulcerative Colitis. Which of the following would not be associated with UC Toxic megacolon Granulomas Pseudopolyps Primary sclerosing cholangitis.
UC. Ulcerative Colitis ( UC ) Ulcerative colitis is an inflammatory bowel disease (IBD) that causes chronic inflammation of the digestive tract It is.
Case A 25-year-old woman A 4-m history of abdominal pain in the left lower quadrant and bloody diarrhea.
Inflammatory Bowel Disease (IBD) Idiopathic IBD is comprised of CD+UC and is characterized by chronic bowel inflammation. Idiopathic IBD is comprised of.
Crohn’s Disease Allie Abraham.
Gastrointestinal Block Pathology lecture Dec, 2012
Crohn’s Disease Kyra Alexander. What is it? An inflammatory bowel disease that causes inflammation of the digestive tract. It is an unpredictable disease.
Non-Neoplastic Colon Disorders Randolph K Peterson, MD Department of Laboratory Medicine and Pathology.
Anna Giles, Surgical Registrar POWH
Inflammatory Bowel Diseases and Drugs. Inflammatory Bowel Diseases Ulcerative Colitis Crohn’s Disease Diverticulitis Irritable Bowel Syndrome*
Nursing Management: Lower Gastrointestinal Problems
Understanding Lower Bowel Disease
Inflammatory Bowel Disease NPN 200 Medical Surgical I.
By: Leon Richardson Period 2
Raneen Omary. Contents Definition Pathogenesis Epidemiology Acute Radiation Enteritis Chronic Radiation Enteritis Risk Factors Diagnosis DD Medical Management.
A Case of Crohn’s Disease Rich Rames, M3 May/June 2013 Dr. Joy Sclamberg, Dr. James Cameron, Dr. Aditi Gulabani.
2012 Physicians Assistance WINTER CONFERENCE March 10, 2012.
Definitions UC Inflammation confined to mucosa Inflammation confined to mucosa Starting in rectum Starting in rectum May involve entire colon May involve.
Cancer colon.
Imaging of IBD and Other Colitides
Which of the following is/are true regarding Ulcerative Colitis (UC)? A. Females are affected more then males. B. Surgery is curative. C. The most consistent.
Inflammatory Bowel Disease (IBD)
Crohn Disease (Regional Enteritis)
Primary Impression. Active Pulmonary TB and Gastrointestinal tuberculosis previous history of TB – No sputum AFB smear was done to see if the patient.
Cronhns & Ulcerative Colitis
Small Bowel, SBO, IBD Outline Small bowel physiology SBO physiology
DIGESTIVE SYSTEM the gastrointestinal tract (GI tract), digestive tract, guts or gut is the system of organs within multicellular organisms that takes.
 Two chronic inflammatory disorders of unknown etiology are Crohn ’ s disease (CD) and ulcerative colitis (UC).  CD is a granulomatous disease that.
Crohn’s Disease BY: Brent Movson, Allison Cobb, Alma Hernandez.
DISEASES OF SMALL INTESTINE. PLAN CROHN’S DISEASE (CD) Etiology and Etiology and Epidemiology of CROHN’S DISEASE Pathology of CROHN’S DISEASE Pathology.
 2 MAJOR GROUPS : 1. ULCERATIVE COLITIS – colon involved 2. CROHN’S DIDEASE – the hole GI tract EPIDEMIOLOGY  most common in whites than in blacks and.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Anatomy and Physiology & Pathophysiology
Kim Eastman RN,MSN, CNS. INFLAMMATORY BOWEL DISEASE  OVERVIEW  IMMUNOLOGIC DISEASE THAT RESULTS IN INTESTINAL INFLAMMATION  ULCERATIVE COLITIS  CROHN’S.
SURGICAL CONDITIONS OF THE INTESTINES
Gastrointestinal Block Pathology lecture Dec, 2015 Dr. Maha Arafah Dr. Ahmed Al Humaidi Inflammatory bowel disease.
DIFFERENTIAL DIAGNOSIS 1.Colon Cancer 2.Colonic obstruction 3.Crohn’s Disease.
Inflammatory Bowel Disease
Ulcerative colitis.
What do these people all have in common?
Inflammatory Bowel Disease (IBD)
Maintenance Systems Unit 5
Gastrointestinal Block Pathology lecture Dec, 2016
Cancer colon.
(I) IBD CROHN DISEASE (granulomatous colitis) ULCERATIVE COLITIS
GIT BLOCK PATHOLOGY PRACTICAL Dr Abdullah Basabein
Care of Patients with Inflammatory Intestinal Disorders
Article by: Zubin Grover , Richard Muir, and Peter lewindon
Maintenance Systems Unit 5
Lecture 12 Gastrointestinal Disorders Inflammatory Bowel Disease
Ulcerative Colitis Definition
Inflammatory bowel disease and Ulcerative colitis
Introduction of Inflammatory bowel disease-Crohn’s disease
Gastrointestinal Nutrition Block Pathology lecture Nov, 2018
Presentation transcript:

Altered Bowel Habits Presented by: Wa’ad Alotibi

Inflammatory bowel disease “IBD” : A chronic relapsing idiopathic inflammatory disorders of GIT likely resulting from unregulated and exaggerated local immune response to normal gut flora and self antigen in susceptible individuals. * a group of chronic intestinal diseases characterized by inflammation of the bowel The most common types : Ulcerative collitis & crohn disease The most common types : Ulcerative collitis & crohn disease

IBD pathogenesis Normally there is balance B/w : 1- factors increasing immune system. 2- host defense that down-regulate inflammation & maintain the integrity of mucosa. Pathogenesis involves tissue injury by these factors: 1- genetic : -first-degree relatives are 3 to 20 times more likely to develop diseas - HLA-DRB1 with U.C., HLA-DR7 and DQ4 with C.D.. - NOD2 is mutated in as many as 25% of C.D.. The NOD2 protin is a component of the cell walls of many bacteria and its expressed in paneth cells. The disease associated mutant form may be defective in responding to bacteria then allowing chronic infection to be established in the intestine and promoting inflammatory reactions by NOD2 –independent pathways Mutation in IL-23 receptor gene  stimulation of IL-17  inflammatory reaction(C.D. and U.C.).

2- immunologic :- CD4+ is a primary damaging agent. IL17 from TH17. Effectiveness of TNF antagonists indicate involvement of TNF in C.D. 3- microbial :- ileum and colon are filled with bacteria  more likely to provide antigenic trigger to a fundamentally dysregulated immune system.

IBD pathogenesis “cont” : Inflammation is the final pathway of pathogenesis. Inflammation causes : 1- impaired integrity of mucosal epithelial barrier. 2- loss of surface epithelial cell absorptive function. Collectively these give rise to intermittent bloody diarrhea

Crohn’s disease: It is characterized by : Sharply limited transmural involvement of the bowel by an inflammatory process with mucosal damage. 1 Noncaseating granuloma. 2 2 Fistula formation. 3 It may affect any level of GIT, but mostly at the terminal ileum.

Morphology : Macroscopic 1-sharply delimited and typically transmural involvement of the bowel by an inflammatory process with mucosal damage 2-noncaseating granulomas 40%-60% 3- fissuring with formation of fistulae 4- in diseased segments the serosa becomes granular and dull gray and often the mesenteric fat wraps around the bowel surface(creeping fat) 5- the intestinal wall is rubbery and thick the result of edema,inflammation,fibrosis and hypertrophy of muscularis propria

Microscopic:  abundant neutrophils that infiltrate and damage crypt epithelium transmural inflamation  -crypt abscesses  -ulceration is common  -and adjacent normal mucosa  -lesions are patchy  Noncaseeating granulomas  -granulomas may in mesenteric lymph nodes  -fibrosing st rictures later on

12 ♥ Recurrent episodes of diarrhea ♥ Crampy abdominal pain ♥ constipation ♥ Fever for days to weeks ♥ Melena 50% in colon involvement Clinical features ♥ Malabsorption syndrome ♥ Fistula formartion ♥ Anal lesions ♥ Extra intestinal: uveitis, migratory polyarthritis, erythema nodosum, ♥ bile duct inflammatory disorders, and obstructive uropathy with attendant nephrolithiasis. ♥ Abdominal abscess and peritonitis ♥ Intestinal stricture or obstruction ♥ Massive bleeding “rare” ♥ Toxic dilation of colon “rare “ ♥ Carcinoma 5-6 times “less than U.C.” Complications :

Ulcerative colitis: Ulceroinflammatory disease affecting Only the colon “it begins in rectum and extend proximally and may involve the entire colon”. It is limited to mucosa and submucosa except in most sever cases.

Morphology : Macroscopic ♥ It is continuous starting from colon “no skip lesion”. ♥ Destruction of mucosa, hyperemia, edema, granularity with friability and easy bleeding. ♥ Broad-base ulceration of mucosa. ♥ Regenerating mucosa bulge upward to create pseudopolyps. ♥ Interconnection of edges of adjacent ulcers create tunnels covered by tenuous mucosal bridges. ♥ Ulcers are aligned along the axis of the colon. ♥ Rarely, perforation and pericolonic abscess formation. ♥ exposure of muscularis propria and neural plexus to fecal material may lead to complete shutdown of neuromuscular function. ♥ Colon swell and become gangrenous (toxic megacolon). ♥ Progressive mucosal atrophy leads to flattened and attenuated mucosal surface.

Microscopic: ♥ ● Mononucleare inflammatory cells in lamina propria. ♥ ● Crypt abscess “neutrophils in epithelial layer. ♥ ● There is no granuloma, although rupture of crypt abscess may incite a foreign body reaction. ♥ ● With remission,granulation tissue fills in the ulcer craters then mucosal epithelium regeneration. ♥ ● Submucosal fibrosis and mucosal architectural disarray and atrophy remain as residua of healed disease.

1 2 Clinical features:- Complications: ♥ Bloody mucoid diarrhea ♥ Cramps, lower abdominal wall “relieved with defecation” ♥ Fever &weight loss ♥ Bloody stool is more in UC than CD ♥ Cancer is times increase risk “higher than CD” ♥ Blood loss  anemia ♥ Diarrhea  electrolytes disturbance ♥ Extra intestinal :migratory polyarthritis “more than CD”, sacroiliitis, ankylosing spondylitis, uveitis, erythema nodosum. ♥ severe colonic dilation (toxic megacolon) with potential rupture, and perforation with peritonitis

Differences Between Crohn’s Disease And Ulcerative Colitis Both are disease which are diagnosed by excluding other common disorders e.g. infectious enterocolitis (Shigella, Salmonella), Ischemic bowel disease and appendicitis. -They are two diseases which have some similarities and some differences. Crohn disease : Granulomatous IBD affecting any portion of gut, specially ileum and sometime colon Ulcerative colitis: IBD without granuloma formation affecting only the colon

Ulcerative colitisCrohn disease (small intestine) Crohn disease (colon) Feature(gross) Colon onlyIleum 30% with colon 40% Colon 30%Bowel region DiffuseSkip lesion Distribution Late/ rareearlyVariableStricture thinthickenedvariableWall appearance yesnoyesDilation

Ulcerative colitisCrohn disease(small intestine) Crohn disease (colon) Microscopic feature Limited to mucosaTransmural inflammation MarkedNone to slightMarkedPseudo polyps SuperficialDeep liner Ulcers MildMarked Lymphoid reaction MildMarkedModerateFibrosis Mild to noneMarkedVariableSerositis NoYes Granulomas Noyes Fistulas

General differences between crohn’s disease and ulcerative colitis Ulcerative colittisCrohns diseaseFactor Intermittent attacks of bloody mucoid,diarrhea, abdominal pain, Exteraintestinal manifestation include migority polyarthritis and sarcolitis Intermittent attacks of diarrhea,fever, abdominal pain,anorexia, weight loss, Intervening asymptomatic periods Exteraintestinal manifestation include migority polyarthritis and sarcolitis Clinical appearance YesMuch less than UCMalignant potential NoYesFat/vitamin malabsorption goodpoorResponse to surgery

Describe non-pharmacological measures used in treatment of IBD and mention the goals of treatment Goals of treatment: - Induce and maintain remission. - Limit drug toxicity. - Modify the pattern of disease. - Avoid complications. - Diagnose malignancy early. Non-pharmacological measures: 1- Nutrition support. 2- Surgery. Non-pharmacological measures: 1- Nutrition support. 2- Surgery.

1- Nutritional support : A. Low lactose diet: to avoid problems of malabsorption. B. Low fiber diet: to reduce symptoms of intestinal obstruction in crohn’s disease. C. Replacement therapy: with iron, protein, water and fat-soluble vitamins, trace elements and electrolytes. D. Total parenteral nutrition if there is : - loss of appetite. - severe illness. - extensive bowel resection - preparation for surgery. - children or adolescent with growth retardation because of crohn’s disease.

2-Surgery % of patients with UC and % of patients with Crohn’s disease require surgical intervention at some point in their life. ♥ Indication of surgery in crohn disease is for complications like: ♥ - Bowel obstruction. ♥ - Abscess or fissures in the anal area. ♥ - Perforations in the large intestine. ♥ - Cancer or precancerous tissue. ♥ - Severe disease that does not respond to other treatment. ♥ - Severe bleeding that requires ongoing blood transfusions. ♥ Indications of surgery in ulcerative colitis : ♥ 1 Uncontrolled disease after maximal medical therapy. ♥ 2 Severe complications of the disease such as : ♥ Colonic perforation. ♥ Toxic dilation of the colon(megacolon) ♥ Uncontrolled colonic hemorrhage ♥ Colonic stricture ♥ Long-standing disease (>8y) ♥ High risk of cancer development (prophylaxis).

List drugs used in treatment of IBD: 1 Aminosalicylates Mesalazine Olsazine Corticosteroids prednisolone hydrocotizone 2 3 Immunosuppressants: Thiopurin Methotrexate Cyclosporin

Crohn’s diseaseUlcerative colitisFeature Whole GITColon and rectumInvolvement PresentAbsentSkip lesions Whole intestinal wall Mucosa and submucosa Transmural infection +++++Crypt abscesses +++++Deep fissures Pseudopolyps ++(50%)NoGranuloma formation ++++Broad ulcers ++++early+lateTransmural fibrosis ++++premalignant poorgoodresponse to surgery

References: